2017
DOI: 10.3892/ol.2017.6634
|View full text |Cite
|
Sign up to set email alerts
|

Protein expression of Fragile Histidine Triad and cyclooxgenase-2 in serrated neoplasia of the colorectum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 34 publications
(47 reference statements)
0
5
0
Order By: Relevance
“…It can be observed that out of the seven studies on SSPND (i.e. SSA/P without dysplasia) (11,47,48,50,51,53,54), only one reported p53 immunoreactivity (50). However, the immunoreactivity in that report was described and illustrated as low and diffuse, affecting the cells of the lower third of the crypts (base) (50).…”
Section: Discussionmentioning
confidence: 95%
See 1 more Smart Citation
“…It can be observed that out of the seven studies on SSPND (i.e. SSA/P without dysplasia) (11,47,48,50,51,53,54), only one reported p53 immunoreactivity (50). However, the immunoreactivity in that report was described and illustrated as low and diffuse, affecting the cells of the lower third of the crypts (base) (50).…”
Section: Discussionmentioning
confidence: 95%
“…Several reports deal with the expression of p53 in SSP without dysplasia and in SSA/P (11,(45)(46)(47)(48)(49)(50)(51)(52)(53)(54). The results of those studies are condensed in Table II.…”
Section: Discussionmentioning
confidence: 99%
“…p16 gene is a multi-tumor suppressor gene that acts primarily on the cell cycle anti-oncogene (15). The study demonstrated that p16 protein mainly competes with cyclin D1 for binding to CDK4/CDK6 and promotes cell arrest in G1 phase, which ultimately plays a negative regulatory role in cell proliferation (16,17).…”
Section: Discussionmentioning
confidence: 99%
“…As described in our previous study on fragile histidine triad and cyclooxygenase-2 expression in serrated neoplasia (19) (5). The 20 HPs were subdivided into ten microvesicular HPs (MVHPs) and ten goblet cell HPs (GCHPs).…”
Section: Methodsmentioning
confidence: 99%
“…All other tumorous lesions in the colon were termed polypoid lesions. The clinical characteristics of the patients are reported in our previous study (19). All cases were de-identified prior to analysis, and written informed consent was obtained from all patients.…”
Section: Methodsmentioning
confidence: 99%